With FDA Approval for RNAi Drug, Arrowhead Pharma Starts Price War With Rival Ionis
Arrowhead Pharmaceuticals’ RNAi drug plozasiran, brand name Redemplo, is now the second FDA-approved therapy for…
With FDA Approval for RNAi Drug, Arrowhead Pharma Starts Price War With Rival Ionis
Arrowhead Pharmaceuticals’ RNAi drug plozasiran, brand name Redemplo, is now the second FDA-approved therapy for familial chylomicronemia syndrome, an inherited lipid disorder. Beyond its claims of safety and dosing advantages, Arrowhead set a dramatically lower price for its first commercial product, which will compete against an Ionis Pharmaceuticals drug. The post With FDA Approval for…
Pyx Health Introduces Platform to Support Those Affected by OBBBA
Pyx Health launched an AI-driven platform to help members navigate care, meet new Medicaid and SNAP requirements and address social needs like food insecurity. The post Pyx Health Introduces Platform to Support Those Affected by OBBBA appeared first on MedCity News.
Access Uncertain for New Injectable PrEP as the Affordable Care Act’s (ACA) Open Enrollment Begins
This analysis examines access to, and consumers ability to find information on, a new twice annual long-acting PrEP drug during the first ACA open enrollment period since its approval. Despite the drug widely being considered a major advance, early evidence suggests that insurance coverage and benefit design decisions may create barriers to access.
The Most Scientifically Advanced Cryopreservation Techniques: Alcor at the Forefront
[Sponsored] Alcor’s combination of medical precision, chemical engineering and ethical governance set it apart from any other organization in the cryonics field. The post The Most Scientifically Advanced Cryopreservation Techniques: Alcor at the Forefront appeared first on MedCity News.
Struggling UnitedHealth Group is a Huge Smoking Black Box
By JEFF GOLDSMITH In mid-April 2025, UnitedHealth Group (UNH) reported its 1Q25 operating results, including a modest shortfall in expected earnings and lowered its 2025 earnings forecast by 12%. The company blamed accelerating medical costs and federal policy changes for their most profitable service line, Medicare Advantage. Market reaction was swift and savage. UNH stock…
USA’s Best Fixed-Wing Air Ambulance Services: Features, Coverage and Reviews
[Sponsored] Each air ambulance service featured has demonstrated excellence, ensuring every flight delivers both precision and compassion in the moments that matter most. The post USA’s Best Fixed-Wing Air Ambulance Services: Features, Coverage and Reviews appeared first on MedCity News.
Why Health Plans Are Reclaiming Utilization Management, and What It Takes to Do It Right
CMS and AHIP are raising the floor, but forward-thinking plans are aiming higher. They’re designing utilization management systems that are clinically sound, operationally efficient, and aligned with enterprise goals. The post Why Health Plans Are Reclaiming Utilization Management, and What It Takes to Do It Right appeared first on MedCity News.
Addressing Operational Inefficiencies in Healthcare Finance to Drive Better Business Decisions
Fragmented finance systems have long caused operational challenges. By addressing this, CFOs can optimize and streamline many finance processes to improve compliance readiness and create time for business-driven decisions that support business objectives. The post Addressing Operational Inefficiencies in Healthcare Finance to Drive Better Business Decisions appeared first on MedCity News.
Paciente evita la enfermedad de Lyme, pero recibe una factura sorpresa
Un fin de semana de fines de abril, Leah Kovitch estaba arrancando plantas invasoras en un prado cerca de su casa cuando una garrapata se le prendió en la pierna. No notó al diminuto insecto hasta el lunes, cuando empezó a sentir dolor en el músculo de la pantorrilla. Esa misma mañana, hizo una cita…
